Jacc: Cardiooncology最新文献

筛选
英文 中文
Cancer Development in Atherosclerotic Cardiovascular Disease 动脉粥样硬化性心血管疾病中的癌症发展
IF 12.8 1区 医学
Jacc: Cardiooncology Pub Date : 2025-08-01 DOI: 10.1016/j.jaccao.2025.05.016
Jessie M. Dalman BA , Kathryn J. Moore PhD
{"title":"Cancer Development in Atherosclerotic Cardiovascular Disease","authors":"Jessie M. Dalman BA , Kathryn J. Moore PhD","doi":"10.1016/j.jaccao.2025.05.016","DOIUrl":"10.1016/j.jaccao.2025.05.016","url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 5","pages":"Pages 514-517"},"PeriodicalIF":12.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis 外周缺血通过骨髓倾斜造血促进乳腺癌
IF 12.8 1区 医学
Jacc: Cardiooncology Pub Date : 2025-08-01 DOI: 10.1016/j.jaccao.2025.07.002
Pilar Martín PhD
{"title":"Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis","authors":"Pilar Martín PhD","doi":"10.1016/j.jaccao.2025.07.002","DOIUrl":"10.1016/j.jaccao.2025.07.002","url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 5","pages":"Pages 578-579"},"PeriodicalIF":12.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144867404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer-Related Immune Therapies 癌症相关免疫疗法
IF 12.8 1区 医学
Jacc: Cardiooncology Pub Date : 2025-08-01 DOI: 10.1016/j.jaccao.2025.06.008
Kapka Miteva PhD , Markus S. Anker MD , Henry Fechner DVM , Lorenz Lehmann MD , Sophie Van Linthout PhD
{"title":"Cancer-Related Immune Therapies","authors":"Kapka Miteva PhD ,&nbsp;Markus S. Anker MD ,&nbsp;Henry Fechner DVM ,&nbsp;Lorenz Lehmann MD ,&nbsp;Sophie Van Linthout PhD","doi":"10.1016/j.jaccao.2025.06.008","DOIUrl":"10.1016/j.jaccao.2025.06.008","url":null,"abstract":"<div><div>Immune-based therapies—including immune checkpoint inhibitors, bispecific T cell engagers, chimeric antigen receptor T cells, and tumor-infiltrating lymphocytes— not only have transformed cancer treatment, but also have introduced significant cardiovascular complications, posing new challenges for cardio-oncology. Growing recognition of cardiovascular immune-related adverse events has spurred research into the immune–cardiovascular interface, particularly dysregulated signaling, T cell overactivation, and cytokine release. This review synthesizes recent insights into the role of immune checkpoints in cardiovascular disease, the mechanisms of immune checkpoint inhibitor– and T cell–induced cardiotoxicity, and the therapeutic potential of immune checkpoint modulation and chimeric antigen receptor T cell therapy in cardiovascular applications.</div></div>","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 5","pages":"Pages 523-537"},"PeriodicalIF":12.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Risk Assessment in Patients With Kidney Cancer 肾癌患者心血管风险评估
IF 12.8 1区 医学
Jacc: Cardiooncology Pub Date : 2025-08-01 DOI: 10.1016/j.jaccao.2025.07.004
Kriti Mittal MD, MS , Jenica N. Upshaw MD, MSc
{"title":"Cardiovascular Risk Assessment in Patients With Kidney Cancer","authors":"Kriti Mittal MD, MS ,&nbsp;Jenica N. Upshaw MD, MSc","doi":"10.1016/j.jaccao.2025.07.004","DOIUrl":"10.1016/j.jaccao.2025.07.004","url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 5","pages":"Pages 641-643"},"PeriodicalIF":12.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Growing Intersection Between Cancer and Cardiovascular Disease 癌症和心血管疾病之间越来越多的交集
IF 12.8 1区 医学
Jacc: Cardiooncology Pub Date : 2025-08-01 DOI: 10.1016/j.jaccao.2025.07.006
Bonnie Ky MD, MSCE, FACC (Editor-in-Chief, JACC: CardioOncology)
{"title":"The Growing Intersection Between Cancer and Cardiovascular Disease","authors":"Bonnie Ky MD, MSCE, FACC (Editor-in-Chief, JACC: CardioOncology)","doi":"10.1016/j.jaccao.2025.07.006","DOIUrl":"10.1016/j.jaccao.2025.07.006","url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 5","pages":"Pages 646-647"},"PeriodicalIF":12.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer and Cardiovascular Disease 癌症和心血管疾病
IF 12.8 1区 医学
Jacc: Cardiooncology Pub Date : 2025-08-01 DOI: 10.1016/j.jaccao.2025.07.001
Laith Alhuneafat MD , Avirup Guha MD, MPH , Anne Blaes MD, MS , Suma H. Konety MD, MS
{"title":"Cancer and Cardiovascular Disease","authors":"Laith Alhuneafat MD ,&nbsp;Avirup Guha MD, MPH ,&nbsp;Anne Blaes MD, MS ,&nbsp;Suma H. Konety MD, MS","doi":"10.1016/j.jaccao.2025.07.001","DOIUrl":"10.1016/j.jaccao.2025.07.001","url":null,"abstract":"<div><div>Cancer and cardiovascular disease (CVD) remain the leading causes of morbidity and mortality worldwide, with emerging evidence highlighting their complex and bidirectional interplay. Shared risk factors, including aging, systemic inflammation, metabolic dysregulation, and lifestyle behaviors, can contribute to their co-occurrence while underlying biological mechanisms such as oxidative stress, chronic inflammation, and clonal hematopoiesis further reinforce their connection. These mechanisms drive pathophysiological changes contributing to disease progression, increasing susceptibility to both conditions. This review explores the epidemiology, overlapping biological pathways, and risk factors linking cancer and CVD, emphasizing key mechanisms such as epigenetic modifications, immune system dysregulation, and cellular senescence. Future research should aim to identify biomarkers, refine risk models, and develop targeted strategies to mitigate disease burden and improve outcomes.</div></div>","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 5","pages":"Pages 453-469"},"PeriodicalIF":12.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluoropyrimidine Therapy in Gastrointestinal Cancer 氟嘧啶治疗胃肠道肿瘤:平衡生存获益和心脏毒性风险。
IF 12 1区 医学
Jacc: Cardiooncology Pub Date : 2025-06-01 DOI: 10.1016/j.jaccao.2025.02.006
Mohamad Bassam Sonbol MD , Tanios Bekaii-Saab MD , Carolyn M. Larsen MD
{"title":"Fluoropyrimidine Therapy in Gastrointestinal Cancer","authors":"Mohamad Bassam Sonbol MD ,&nbsp;Tanios Bekaii-Saab MD ,&nbsp;Carolyn M. Larsen MD","doi":"10.1016/j.jaccao.2025.02.006","DOIUrl":"10.1016/j.jaccao.2025.02.006","url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 4","pages":"Pages 357-359"},"PeriodicalIF":12.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Full Issue PDF 完整版PDF
IF 12 1区 医学
Jacc: Cardiooncology Pub Date : 2025-06-01 DOI: 10.1016/S2666-0873(25)00240-6
{"title":"Full Issue PDF","authors":"","doi":"10.1016/S2666-0873(25)00240-6","DOIUrl":"10.1016/S2666-0873(25)00240-6","url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 4","pages":"Pages I-CXXXII"},"PeriodicalIF":12.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144307900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Care After Cancer 癌症后的心血管护理
IF 12 1区 医学
Jacc: Cardiooncology Pub Date : 2025-06-01 DOI: 10.1016/j.jaccao.2025.05.005
Nina Nouhravesh MD, PhD, Morten Schou MD, PhD
{"title":"Cardiovascular Care After Cancer","authors":"Nina Nouhravesh MD, PhD,&nbsp;Morten Schou MD, PhD","doi":"10.1016/j.jaccao.2025.05.005","DOIUrl":"10.1016/j.jaccao.2025.05.005","url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 4","pages":"Pages 379-381"},"PeriodicalIF":12.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144308057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitigation of Doxorubicin Cardiotoxicity With Synergistic miRNA Combinations Identified Using Combinatorial Genetics en masse (CombiGEM) 使用组合遗传学集体(CombiGEM)鉴定的协同miRNA组合减轻阿霉素心脏毒性
IF 12 1区 医学
Jacc: Cardiooncology Pub Date : 2025-06-01 DOI: 10.1016/j.jaccao.2025.03.007
Yasutomi Higashikuni MD, PhD , Colin Platt PhD , Margaret H. Hastings PhD , William C.W. Chen MD, PhD , Justin R.B. Guerra BS , Takeshi Tokuyama PhD , Fuad Gandhi Torizal DDS, PhD , Wenhao Liu MD , Takumi Obana , Abraham L. Bayer BS , Hannah Whipple BS , Alexandra Kuznetsov BA , Ashish Yeri PhD , Cole Turissini BS , Robert R. Kitchen PhD , Kota Shibayama , Takayoshi Matsumura MD, PhD , Norihiko Takeda MD, PhD , Hideki Uosaki MD, PhD , Aarti H. Asnani MD , Anthony Rosenzweig MD
{"title":"Mitigation of Doxorubicin Cardiotoxicity With Synergistic miRNA Combinations Identified Using Combinatorial Genetics en masse (CombiGEM)","authors":"Yasutomi Higashikuni MD, PhD ,&nbsp;Colin Platt PhD ,&nbsp;Margaret H. Hastings PhD ,&nbsp;William C.W. Chen MD, PhD ,&nbsp;Justin R.B. Guerra BS ,&nbsp;Takeshi Tokuyama PhD ,&nbsp;Fuad Gandhi Torizal DDS, PhD ,&nbsp;Wenhao Liu MD ,&nbsp;Takumi Obana ,&nbsp;Abraham L. Bayer BS ,&nbsp;Hannah Whipple BS ,&nbsp;Alexandra Kuznetsov BA ,&nbsp;Ashish Yeri PhD ,&nbsp;Cole Turissini BS ,&nbsp;Robert R. Kitchen PhD ,&nbsp;Kota Shibayama ,&nbsp;Takayoshi Matsumura MD, PhD ,&nbsp;Norihiko Takeda MD, PhD ,&nbsp;Hideki Uosaki MD, PhD ,&nbsp;Aarti H. Asnani MD ,&nbsp;Anthony Rosenzweig MD","doi":"10.1016/j.jaccao.2025.03.007","DOIUrl":"10.1016/j.jaccao.2025.03.007","url":null,"abstract":"<div><h3>Background</h3><div>Cardiomyocyte loss occurs in acute and chronic cardiac injury, including cardiotoxicity due to chemotherapeutics like doxorubicin, and contributes to heart failure development. There is a pressing need for cardiac-specific therapeutics that target cardiomyocyte loss, preventing chemotherapy complications without compromising chemotherapeutic efficacy.</div></div><div><h3>Objectives</h3><div>The authors employed massively parallel combinatorial genetic screening to find microRNA (miRNA) combinations that promote cardiomyocyte survival.</div></div><div><h3>Methods</h3><div>CombiGEM (combinatorial genetics en masse) screening in a cardiomyocyte cell line was followed by validation in the original cell type and screening in primary cardiomyocytes. The top combination was tested in mouse and developing zebrafish models of doxorubicin cardiotoxicity. RNA sequencing provided insight into possible mechanisms.</div></div><div><h3>Results</h3><div>Multiple miRNA combinations protected cardiomyocytes from doxorubicin in vitro. The most effective (miR-222+miR-455) appeared to act synergistically, and mitigated doxorubicin cardiotoxicity phenotypes in murine and zebrafish in vivo models. RNA sequencing revealed overlapping and synergistic regulation of relevant genes and biological processes in cardiomyocytes, including mitochondrial homeostasis, oxidative stress, muscle contraction, and others.</div></div><div><h3>Conclusions</h3><div>We identified miR-222 and miR-455 as a combination with potential therapeutic applications for cardioprotection. This study furthers our knowledge of the cardiac effects of miRNAs and their combinations and demonstrates the potential of CombiGEM for cardioprotective combinatorial therapeutic discovery.</div></div>","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"7 4","pages":"Pages 396-410"},"PeriodicalIF":12.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144042417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信